● Recruiting

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Condition: Atopic Dermatitis · Atopic · Dermatitis · Sponsor: Apollo Therapeutics Ltd

PhasePhase 2

Planned participants280

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (85)

AllerVie Clinical Research	Birmingham, Alabama, United States	Not Yet Recruiting
Cahaba Dermatology and Skin Health Center	Birmingham, Alabama, United States	Not Yet Recruiting
Saguaro Dermatology Associates	Phoenix, Arizona, United States	Not Yet Recruiting
Dermatology Trial Associates, Inc	Bryant, Arkansas, United States	Not Yet Recruiting
Marvel Research, LLC	Huntington Beach, California, United States	Not Yet Recruiting
Metropolis Dermatology	Los Angeles, California, United States	Not Yet Recruiting
Dermatology Research Associates	Los Angeles, California, United States	Not Yet Recruiting
University of California Los Angeles	Los Angeles, California, United States	Not Yet Recruiting
Northridge Clinical Trials	Northridge, California, United States	Recruiting
Integrative Skin Science and Research	Sacramento, California, United States	Recruiting
Valiance Clinical Research - Tarzana	Tarzana, California, United States	Not Yet Recruiting
Paradigm Clinical Research Centers, LLC: Wheat Ridge	Wheat Ridge, Colorado, United States	Not Yet Recruiting

+ 73 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07599813